(Q40037006)

English

Decisive role of cyclooxygenase-2 and lipocalin-type prostaglandin D synthase in chemotherapeutics-induced apoptosis of human cervical carcinoma cells

scientific article published on 10 December 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Decisive role of cyclooxygenase-2 and lipocalin-type prostaglandin D synthase in chemotherapeutics-induced apoptosis of human cervical carcinoma cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

1 reference

based on heuristic

inferred from title

author name string

Eichele K

1

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Ramer R

2

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Hinz B

3

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

language of work or name

0 references

publication date

10 December 2007

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

3032-3044

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

https://scigraph.springernature.com/pub.10.1038/sj.onc.1210962

0 references

Celecoxib, a selective cyclo-oxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210962

21 January 2018

Phase I and pharmacokinetic study of docetaxel, irinotecan, and celecoxib in patients with advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210962

21 January 2018

A yeast two-hybrid technology-based system for the discovery of PPARgamma agonist and antagonist

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210962

21 January 2018

Prostaglandin D(2) and J(2) induce apoptosis in human leukemia cells via activation of the caspase 3 cascade and production of reactive oxygen species

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210962

21 January 2018

Influence of J series prostaglandins on apoptosis and tumorigenesis of breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210962

21 January 2018

Targeting cyclooxygenase-2 in recurrent non-small cell lung cancer: a phase II trial of celecoxib and docetaxel

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210962

21 January 2018

Pharmacokinetics and pharmacodynamics of combination chemotherapy with paclitaxel and epirubicin in breast cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210962

21 January 2018

Induction of G0/G1 cell cycle arrest in ovarian carcinoma cells by the anti-inflammatory drug NS-398, but not by COX-2-specific RNA interference.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210962

21 January 2018

The role of cyclooxygenase in n-6 and n-3 polyunsaturated fatty acid mediated effects on cell proliferation, PGE(2) synthesis and cytotoxicity in human colorectal carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210962

21 January 2018

R(+)-methanandamide elicits a cyclooxygenase-2-dependent mitochondrial apoptosis signaling pathway in human neuroglioma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210962

21 January 2018

Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210962

21 January 2018

Up-regulation of cyclooxygenase-2 expression is involved in R(+)-methanandamide-induced apoptotic death of human neuroglioma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210962

21 January 2018

National Cancer Institute workshop on chemopreventive properties of nonsteroidal anti-inflammatory drugs: role of COX-dependent and -independent mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210962

21 January 2018

Suppression of prostate tumor cell growth by stromal cell prostaglandin D synthase-derived products

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210962

21 January 2018

Increase in PGE2 biosynthesis induces a Bax dependent apoptosis correlated to patients' survival in glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210962

21 January 2018

Binding, degradation and apoptotic activity of stearoylethanolamide in rat C6 glioma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210962

21 January 2018

ET-18-O-CH3-induced apoptosis is causally linked to COX-2 upregulation in H-ras transformed human breast epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210962

21 January 2018

Peroxisome proliferator-activated receptor γ (PPARγ) ligands as bifunctional regulators of cell proliferation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210962

21 January 2018

Docetaxel and cyclooxygenase-2 inhibition with celecoxib for advanced non-small cell lung cancer progressing after platinum-based chemotherapy: a multicenter phase II trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210962

21 January 2018

A phase II trial of irinotecan, 5-fluorouracil and leucovorin combined with celecoxib and glutamine as first-line therapy for advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210962

21 January 2018

Ceramide Is Involved inR(+)-Methanandamide-Induced Cyclooxygenase-2 Expression in Human Neuroglioma Cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210962

21 January 2018

Suppression of chondrosarcoma cells by 15-deoxy-Delta 12,14-prostaglandin J2 is associated with altered expression of Bax/Bcl-xL and p21.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210962

21 January 2018

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210962

21 January 2018

Overexpression of COX-2 in human osteosarcoma cells decreases proliferation and increases apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210962

21 January 2018

Malignant transformation and antineoplastic actions of nonsteroidal antiinflammatory drugs (NSAIDs) on cyclooxygenase-null embryo fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210962

21 January 2018

Tumorigenic transformation of immortalized ECV endothelial cells by cyclooxygenase-1 overexpression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210962

7 January 2021

based on heuristic

inferred from DOI database lookup

Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210962

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.ONC.1210962

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40037006&oldid=1882965178"